Mark Mallon

2019

In 2019, Mark Mallon earned a total compensation of $10.1M as Chief Executive Officer at Ironwood Pharmaceuticals.

Compensation breakdown

Bonus$880,000
Non-Equity Incentive Plan$797,063
Option Awards$3,804,331
Salary$750,000
Stock Awards$3,692,810
Other$144,596
Total$10,068,800

Mallon received $3.8M in option awards, accounting for 38% of the total pay in 2019.

Mallon also received $880K in bonus, $797.1K in non-equity incentive plan, $750K in salary, $3.7M in stock awards and $144.6K in other compensation.

Rankings

In 2019, Mark Mallon's compensation ranked 743rd out of 13,971 executives tracked by ExecPay. In other words, Mallon earned more than 94.7% of executives.

ClassificationRankingPercentile
All
743
out of 13,971
95th
Division
Manufacturing
262
out of 5,701
95th
Major group
Chemicals And Allied Products
69
out of 2,200
97th
Industry group
Drugs
58
out of 1,886
97th
Industry
Pharmaceutical Preparations
47
out of 1,398
97th

Pay ratio

Mark Mallon's Pay$10,068,800
Median Employee's Pay$202,151
Pay Ratio

50

to 1

In 2019, the annual total compensation of Mark Mallon was $10,068,800.

The annual total compensation of the median employee at Ironwood Pharmaceuticals was $202,151.

The ratio of Mark Mallon's pay to the pay of median employee was therefore 50 to one.

Source: SEC filing on April 21, 2020.

Mallon's colleagues

We found five more compensation records of executives who worked with Mark Mallon at Ironwood Pharmaceuticals in 2019.

2019

Peter Hecht

Ironwood Pharmaceuticals

Chief Executive Officer

2019

Thomas McCourt

Ironwood Pharmaceuticals

President

2019

Mark Currie

Ironwood Pharmaceuticals

Chief Scientific Officer

2019

Gina Consylman

Ironwood Pharmaceuticals

Chief Financial Officer

2019

Halley Gilbert

Ironwood Pharmaceuticals

Chief Administrative Officer

News

You may also like